Product Information
CLOZARIL 100 MG TABLET is a brand product labeled by HLS Therapeutics (USA), Inc., priced at $16.8332 per EA under NDC 69809012705. Its NADAC has been published 356 times since Sep 6, 2017.
FDA first approved this application on Sep 26, 1989. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
HLS Therapeutics (USA), Inc.NDC
69809012705
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
6/1/2026
Active Ingredients
CLOZAPINEApproval Type
New Drug (NDA)
FDA Application
NDA019758FDA Approved
9/26/1989
TE Code
AB
On Market Since
5/6/2016
Pharmacological Classes
Price Statistics
The NADAC for CLOZARIL 100 MG TABLET has been published 356 times since Sep 6, 2017, and over the history we have for it it has risen 23.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.8332 per EA |
|---|---|
| All-time high | $16.8332 (Sep 30, 2026) |
| All-time low | $13.3579 (Feb 21, 2018) |
| 52-week high | $16.8332 |
| 52-week low | $16.1935 |
| Median price | $14.5335 |
| Average price | $14.9513 |
| Largest weekly change | +4.9% (Apr 4, 2018) |
| Weeks tracked | 356 |
| Tracking since | Sep 6, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
HLS Therapeutics (USA), Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clozapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOZARIL 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLOZARIL 100 MG TABLET, manufactured by HLS Therapeutics (USA), Inc., is $16.8332 per EA (NDC 69809012705), effective Sep 30, 2026.
How has the price of CLOZARIL 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLOZARIL 100 MG TABLET has risen 23.4%. It has been tracked across 356 weekly CMS publications since Sep 6, 2017.
What are the highest and lowest recorded NADAC prices for CLOZARIL 100 MG TABLET?
Since Sep 6, 2017, the NADAC for CLOZARIL 100 MG TABLET has ranged from a low of $13.3579 (Feb 21, 2018) to a high of $16.8332 (Sep 30, 2026), with a median of $14.5335 per EA.
Are there cheaper alternatives to CLOZARIL 100 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOZAPINE 100 MG TABLET, is $0.6103 per EA — about 96% below CLOZARIL 100 MG TABLET.
Who manufactures CLOZARIL 100 MG TABLET?
CLOZARIL 100 MG TABLET (NDC 69809012705) is labeled by HLS Therapeutics (USA), Inc., and CMS classifies it as a brand product.